APA (7th ed.) Citation

Blumenfeld, A. M., Mechtler, L., Cook, L., Rhyne, C., Jenkins, B., Hughes, O., . . . Diamond, M. (2024). Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review. Pain & Therapy, 13(6), 1571. https://doi.org/10.1007/s40122-024-00649-8

Chicago Style (17th ed.) Citation

Blumenfeld, Andrew M., Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, and Merle Diamond. "Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review." Pain & Therapy 13, no. 6 (2024): 1571. https://doi.org/10.1007/s40122-024-00649-8.

MLA (9th ed.) Citation

Blumenfeld, Andrew M., et al. "Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review." Pain & Therapy, vol. 13, no. 6, 2024, p. 1571, https://doi.org/10.1007/s40122-024-00649-8.